Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 20:47:22 - browse：59527

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Researchers use wearables data and AI to predict preterm birth risk

focus

WSS

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Why Sanofi got shellacked over its spinoff

How one patient went off dialysis — and others can too

Eli Lilly to pay $200M for Beam’s stake in gene

Would Medicare drug price negotiations stall in a shutdown?

WHO may add ‘noma' to its list of neglected tropical diseases

knowledge

Wikipedia

entertainment

At least 13 dead in Texas as scorching temps continue

FDA advisers vote against ALS treatment from BrainStorm

BioMarin wins approval for gene therapy to treat hemophilia A

Why Sanofi got shellacked over its spinoff

In age of alternative facts, a scholarly course on calling out crap

WHO recommends dropping component of many flu vaccines

Drug repurposing or repositioning? The language matters

Researchers use wearables data and AI to predict preterm birth risk

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Diversifying clinical trials isn't enough to close racial gaps: study

hotspot

Cigna to pay $172 million to settle Medicare Advantage fraud probe

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Data show record exodus of life scientists from academia

WHO may add ‘noma' to its list of neglected tropical diseases

The pink breast cancer awareness ribbon needs a redesign

Medtronic CEO on promising devices for diabetes, hypertension

explore

focus

focus

explore